Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Memoli

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Science (New York, N.Y.)|January 28, 2017
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severityTaia T Wang, Jaturong Sewatanon, Matthew J Memoli, et al.
NPJ Vaccines|March 21, 2020
Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge studyOlga Pleguezuelos, Emma James, Ana Fernandez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2019
Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine DevelopmentMatthew J Memoli, Alison Han, Kathie-Anne Walters, et al.
The Journal of Infectious Diseases|August 23, 2021
Sex Differences in Influenza: The Challenge Study ExperienceLuca T Giurgea, Adriana Cervantes-Medina, Kathie-Anne Walters, et al.
Journal of Clinical and Translational Science|February 9, 2023
Leveraging CTSA hubs for rapid, large-scale, high-impact research: A case study during a global public health emergencyJennifer A Croker, Shannon Valenti, Holly Ann Baus, et al.
Journal of Clinical Immunology|March 16, 2021
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal BetacoronavirusesJennifer Hicks, Carleen Klumpp-Thomas, Heather Kalish, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 19, 2020
Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge ModelAlison Han, Lindsay Czajkowski, Luz Angela Rosas, et al.
Mbio|April 11, 2019
Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific AntibodiesJin Gao, Laura Couzens, David F Burke, et al.
Mbio|January 9, 2024
Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteersRachel Bean, Luca T Giurgea, Alison Han, et al.
Ebiomedicine|November 27, 2022
Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trialDeAnna J Friedman-Klabanoff, Megan Birkhold, Mara T Short, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Science (New York, N.Y.)|January 28, 2017
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severityTaia T Wang, Jaturong Sewatanon, Matthew J Memoli, et al.
NPJ Vaccines|March 21, 2020
Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge studyOlga Pleguezuelos, Emma James, Ana Fernandez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2019
Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine DevelopmentMatthew J Memoli, Alison Han, Kathie-Anne Walters, et al.
The Journal of Infectious Diseases|August 23, 2021
Sex Differences in Influenza: The Challenge Study ExperienceLuca T Giurgea, Adriana Cervantes-Medina, Kathie-Anne Walters, et al.
Journal of Clinical and Translational Science|February 9, 2023
Leveraging CTSA hubs for rapid, large-scale, high-impact research: A case study during a global public health emergencyJennifer A Croker, Shannon Valenti, Holly Ann Baus, et al.
Journal of Clinical Immunology|March 16, 2021
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal BetacoronavirusesJennifer Hicks, Carleen Klumpp-Thomas, Heather Kalish, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 19, 2020
Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge ModelAlison Han, Lindsay Czajkowski, Luz Angela Rosas, et al.
Mbio|April 11, 2019
Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific AntibodiesJin Gao, Laura Couzens, David F Burke, et al.
Mbio|January 9, 2024
Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteersRachel Bean, Luca T Giurgea, Alison Han, et al.
Ebiomedicine|November 27, 2022
Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trialDeAnna J Friedman-Klabanoff, Megan Birkhold, Mara T Short, et al.
Pageof 7